討論:酰基載體蛋白
 |
本條目頁依照頁面評級標準評為小作品級。 本條目頁屬於下列維基專題範疇： |
||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|||||||||||||||||
未翻譯內容
未翻譯內容如下：--Flame 歡迎泡茶 2011年5月7日 (六) 00:19 (UTC)
首先，fulfils two demands in these biosynthetic pathways. First, the intermediates remain covalently linked to the synthases (or synthetases) in an energy-rich linkage. Second, the flexibility and length of phosphopantetheine chain (approximately 2 nm) allows the covalently-tethered intermediates to have access to spatially-distinct enzyme-active sites. This increases the effective molarity of the intermediate and allows an assemblyline-like process.
The ACPs are small negatively-charged α-helical bundle proteins with a high degree of structural and amino acid similarity. The structures of a number of acyl carrier proteins have been solved using various 蛋白質核磁共振光譜與X光結晶學的技術。
The ACPs are related in structure and mechanism to the peptidyl carrier proteins (PCP) from nonribosomal peptide synthases.
- 翻譯完畢——Shakiestone (留言) 2011年9月13日 (二) 10:21 (UTC)